The Garcia laboratory is a state of the art pulmonary research lab focusing on the genetics and proteomics of lung biology and disease. Our goal is to understand the molecular mechanisms of lung inflammatory processes, particularly those producing lung edema or vascular leak. The laboratory encompasses a mosaic of specialized talents to investigate all aspects of research including gene discovery, protein function assessment, SNP discovery, genetic manipulation, in vivo testing, and candidate gene and biomarker identification. Using this bench-to-bedside approach, we hope to translate our basic research into potential novel clinical therapies.
Joe G. N. "Skip" Garcia, MD, is the University of Arizona endowed Merlin K. DuVal MD Professor of Medicine, founder/CEO of Aqualung Therapeutics,and an elected member of the Institute of Medicine of the National Academies. An internationally noted physician-scientist, health administrator, scholar and educator, Dr. Garcia is also a leading authority on the genetic basis of lung disease with emphasis on health disparities, particularly of the underserved minorities. His research attempts to elucidate key genes and biomarkers that predict individual risk in disease and provides individualized treatment options for physicians to practice personalized medicine.
Dr. Garcia earned his Bachelor of Science in biology at the University of Dallas in 1976 and received his medical degree from the University of Texas Southwestern Medical School in 1980. He completed an internship and residency in internal medicine at the University of Iowa Hospitals and Clinics (1980-1983) and completed a fellowship in pulmonary and critical care medicine at Albany Medical College (1983-1985). His prior leadership positions include Director of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University (1998-2005), Chairman of the Department of Medicine at the University of Chicago (2005-2009), and Vice Chancellor for Research (2010-2012) Vice President for Health Affairs at University of Illinois at Chicago (2011-2013), and Senior Vice President for Health Sciences at the University of Arizona (2013-2016).
Dr. Garcia is internationally recognized for his genetic-based research on lung disease and for development of novel therapies for critically ill patients with acute inflammatory lung disease. He has nearly 400 peer-reviewed publications. He has an expansive portfolio of NIH-sponsored research and continues to direct large federally funded programs. Dr. Garcia is a passionate advocate for the training of physician-scientists and is an active supporter of minority medical and science students. He has nurtured many minority students at Johns Hopkins University, University of Chicago, UIC, and UA, guiding them into MD and PhD programs.